Gutman M - Search Results

1

Failure of thalidomide to inhibit tumor growth and angiogenesis in vivo.

Gutman M, Szold A, Ravid A, Lazauskas T, Merimsky O, Klausner JM. Gutman M, et al. Anticancer Res. 1996 Nov-Dec;16(6B):3673-7. Anticancer Res. 1996. PMID: 9042240

2

Synergism of tumor necrosis factor-alpha and melphalan in systemic and regional administration: animal study.

Gutman M, Sofer D, Lev-Chelouche D, Merimsky O, Klausner JM. Gutman M, et al. Invasion Metastasis. 1997;17(4):169-75. Invasion Metastasis. 1997. PMID: 9778589

3

Intra-arterial chemotherapy with concomitant hemofiltration (chemofiltration) for treatment of loco-regional or pelvic metastases from malignant melanoma.

Gutman M, Abu-Abid S, Inbar M, Lev D, Chaitchik S, Sorkin P, Klausner JM. Gutman M, et al. Melanoma Res. 1996 Apr;6(2):167-71. doi: 10.1097/00008390-199604000-00012. Melanoma Res. 1996. PMID: 8791275

4

Increased microvascular permeability induced by prolonged interleukin-2 administration is attenuated by the oxygen-free-radical scavenger dimethylthiourea.

Gutman M, Laufer R, Eisenthal A, Goldman G, Ravid A, Inbar M, Klausner JM. Gutman M, et al. Cancer Immunol Immunother. 1996 Dec;43(4):240-4. doi: 10.1007/s002620050328. Cancer Immunol Immunother. 1996. PMID: 9003470

5

Establishment of a reproducible transplantable sarcoma in a rat.

Gutman M, Isakov J, Klausner JM. Gutman M, et al. In Vivo. 1997 Mar-Apr;11(2):153-6. In Vivo. 1997. PMID: 9179608

6

Anatomic site of primary melanoma is associated with depth of invasion.

Hemo Y, Gutman M, Klausner JM. Hemo Y, et al. Among authors: gutman m. Arch Surg. 1999 Feb;134(2):148-50. doi: 10.1001/archsurg.134.2.148. Arch Surg. 1999. PMID: 10025453

7

Limb desmoid tumors: a possible role for isolated limb perfusion with tumor necrosis factor-alpha and melphalan.

Lev-Chelouche D, Abu-Abeid S, Nakache R, Issakov J, Kollander Y, Merimsky O, Meller I, Klausner JM, Gutman M. Lev-Chelouche D, et al. Among authors: gutman m. Surgery. 1999 Nov;126(5):963-7. doi: 10.1016/s0039-6060(99)70039-5. Surgery. 1999. PMID: 10568198

8

Hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan in advanced soft-tissue sarcomas: histopathological considerations.

Issakov J, Merimsky O, Gutman M, Kollender Y, Lev-Chelouche D, Abu-Abid S, Lifschitz-Mercer B, Inbar M, Klausner JM, Meller I. Issakov J, et al. Among authors: gutman m. Ann Surg Oncol. 2000 Mar;7(2):155-9. doi: 10.1007/s10434-000-0155-1. Ann Surg Oncol. 2000. PMID: 10761796

9

Isolated limb perfusion with high-dose tumor necrosis factor alpha and melphalan for Kaposi sarcoma.

Lev-Chelouche D, Abu-Abeid S, Merimsky O, Isakov J, Kollander Y, Meller I, Klausner JM, Gutman M. Lev-Chelouche D, et al. Among authors: gutman m. Arch Surg. 1999 Feb;134(2):177-80. doi: 10.1001/archsurg.134.2.177. Arch Surg. 1999. PMID: 10025459 Clinical Trial.

10

Late recurrence of stage I malignant melanoma.

Gutman M, Klausner JM, Inbar M, Rozin RR. Gutman M, et al. J Surg Oncol. 1989 Oct;42(2):96-8. doi: 10.1002/jso.2930420206. J Surg Oncol. 1989. PMID: 2796353

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

471 results

Search Page

Filters